The DOI matches its Crossref record.
Feedback Loop Regulation between Pim Kinases and Tax Keeps Human T-Cell Leukemia Virus Type 1 Viral Replication in Check
Open accessAbstract
The Pim family of protein kinases have established pro-oncogenic functions. They are often upregulated in cancer; especially leukemias and lymphomas.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite driving initial viral sense transcription from the 5′LTR, Tax protein is mostly undetectable in chronic infection due to subsequent methylations and proviral deletions elicited by HTLV-1 immune escape mechanisms [223,224].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [224]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 62
- 10.12688/f1000research.17479.1 · DOI
- 10.3389/fmicb.2012.00388 · DOI · Paper page
- 10.1111/bjh.15234 · DOI
- 10.1186/s12977-020-0511-0 · DOI
- 10.1002/ijc.2910540411 · DOI
- 10.1073/pnas.86.14.5620 · DOI
- 10.1002/ijc.20007 · DOI
- 10.1073/pnas.0507631103 · DOI
- 10.3390/v8060161 · DOI
- 10.1038/sj.onc.1208975 · DOI
- 10.3390/v3060714 · DOI
- 10.1073/pnas.94.25.13897 · DOI
- 10.1073/pnas.1010722107 · DOI
- 10.1073/pnas.1601537113 · DOI
- 10.1182/blood-2008-01-134692 · DOI
- Bellon M, Nicot C. 2015. Multiple pathways control the reactivation of telomerase in HTLV-1-associated leukemia. Int J Cancer Oncol 2.
- 10.1089/08892220050193128 · DOI
- 10.1016/j.lfs.2020.117866 · DOI
- 10.1016/j.drup.2011.04.002 · DOI
- 10.1182/blood-2015-11-685032 · DOI
- Jean-Baptiste D, Belrose G, Meniane JC, Lézin A, Jeannin S, Mesnard JM, Olindo S, Peloponese JM, Jr, Césaire R. 2017. Differential effects of AZD-1208 and SMI-4a, two Pim-1 kinase inhibitors on primary HAM/TSP and ATL cells. Annals of Carcinogenesis 2.
- 10.1186/s13045-014-0095-z · DOI
- 10.1111/ejh.12940 · DOI
- 10.1128/JVI.02682-13 · DOI
- 10.1016/j.virol.2006.03.037 · DOI
- 10.1371/journal.ppat.1000324 · DOI
- 10.1155/2001/896953 · DOI
- 10.1016/j.virol.2005.01.001 · DOI
- 10.1038/s41467-019-09867-7 · DOI
- 10.1111/j.1365-2567.2005.02201.x · DOI
- 10.1126/science.1260419 · DOI · Paper page
- 10.1126/science.aal3321 · DOI · Paper page
- 10.1126/science.aan2507 · DOI · Paper page
- 10.1586/ehm.11.69 · DOI
- 10.1182/blood-2009-08-241117 · DOI
- 10.1128/JVI.00232-09 · DOI
- 10.1016/0042-6822(92)90320-O · DOI
- 10.1074/jbc.M611629200 · DOI
- 10.1128/JVI.02006-13 · DOI
- 10.1182/blood-2008-10-185660 · DOI
- 10.1073/pnas.1716673115 · DOI
- 10.1128/JVI.78.21.11823-11832.2004 · DOI
- 10.3389/fmicb.2013.00231 · DOI
- 10.1128/JVI.01790-07 · DOI
- 10.1016/0168-1702(93)90099-9 · DOI
- 10.1006/viro.1994.1581 · DOI
- 10.1006/viro.1997.8781 · DOI
- Ionov Y, Le X, Tunquist BJ, Sweetenham J, Sachs T, Ryder J, Johnson T, Lilly MB, Kraft AS. 2003. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects. Anticancer Res 23:167–178.
- 10.1128/MCB.10.4.1680 · DOI
- 10.1158/1541-7786.MCR-04-0192 · DOI
- 10.1006/bbrc.2001.4405 · DOI
- 10.4161/auto.4761 · DOI
- 10.1111/cas.12540 · DOI
- 10.1073/pnas.1715724115 · DOI
- 10.1038/bcj.2015.46 · DOI
- 10.1172/JCI95407 · DOI
- 10.1038/bcj.2016.73 · DOI
- 10.1186/s12943-021-01370-2 · DOI
- 10.1371/journal.pone.0042226 · DOI
- 10.1016/j.pharmthera.2015.03.001 · DOI
- 10.3389/fmicb.2020.00356 · DOI · Paper page
- 10.1038/leu.2016.379 · DOI
Cited by
Sorted by citations
Current State of Therapeutics for HTLV-1
Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22
“Treatments for HTLV-1-associated diseases and infection.”
Metadata
- Authors
- Bellon, M., & Nicot, C.
- Affiliations
- University of Kansas Medical Center (US)
- Corresponding author
- Bellon, Marcia
- ORCID
- Nicot, Christophe
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2022-02-09
- Volume
- 96
- Issue
- 3
- Pages
- e0196021-e0196021
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC8826812
- OpenAlex
- W3215172558
- Cited by
- 11
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 1
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | NIH | National Cancer Institute (CA201309)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- PIM kinases, HTLV-1, taxation, PIM-1, PIM2, PIM3, T-cell leukemia, viral replication, viral latency, protein half-life, heat shock, immune evasion, oncogenic transformation, viral persistence
- MeSH terms
- Cell Line, Disease Susceptibility, Humans, Models, Molecular, Transcription Factors, Virus Replication, Human T-lymphotropic virus 1, HTLV-I Infections, Gene Expression Regulation, Viral, Gene Products, tax, HSP90 Heat-Shock Proteins, Terminal Repeat Sequences, Proteasome Endopeptidase Complex, Proto-Oncogene Proteins c-pim-1, Host-Pathogen Interactions, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review